Arvinas ARVN
NASDAQ ARVN
$9.35 +0.03 (+0.38%)
As of: Sep 4, 2026 · 2:31 PM EDT

Arvinas (ARVN) Change in Account Payables (2017 - 2022)

Arvinas (ARVN) posted quarterly Change in Account Payables of -$22.6 million for Q1 2022, down 1355.56% year-over-year from $1.8 million in Q1 2021, and down 186.17% quarter-over-quarter from $26.2 million in Q4 2021.

Analysis

Arvinas (ARVN) Change in Account Payables (2017 - 2022) Analysis & Trends

Arvinas' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$22.6 million for Q1 2022.

  • In Q1 2022, Change in Account Payables fell 1355.56% year-over-year to -$22.6 million; the TTM figure through Mar 2022 stood at -$700000.0 (down 112.26% YoY), while the FY2021 annual figure was $23.7 million, up 1085.0% from the prior year.
  • Change in Account Payables for Q1 2022 stood at -$22.6 million, down from $26.2 million in the prior quarter.
  • The five-year high for Change in Account Payables was $26.2 million in Q4 2021, with the low at -$22.6 million in Q1 2022.
  • The 5-year median for Change in Account Payables is $284784.0 (2019), against an average of $388362.5.
  • The sharpest annual moves came in 2021 and 2022: Change in Account Payables surged 1067.29% in 2021, then slumped 1355.56% in 2022.
  • Arvinas' Change in Account Payables stood at $1.3 million in 2018, then soared by 63.26% to $2.1 million in 2019, then grew by 6.03% to $2.2 million in 2020, then soared by 1067.29% to $26.2 million in 2021, then plunged by 186.17% to -$22.6 million in 2022.
  • Business Quant data shows ARVN's Change in Account Payables at -$22.6 million in Q1 2022, $26.2 million in Q4 2021, and -$82863.0 in Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 5.03 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Arvinas 605.56 Mn 37.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -22.60 Mn
Dec 31, 2021 26.23 Mn
Sep 30, 2021 -82,863.00
Jun 30, 2021 -4.24 Mn
Mar 31, 2021 1.80 Mn
Dec 31, 2020 2.25 Mn
Sep 30, 2020 2.03 Mn
Jun 30, 2020 -367,912.00
Mar 31, 2020 -1.91 Mn
Dec 31, 2019 2.12 Mn
Sep 30, 2019 800,497.00
Jun 30, 2019 284,784.00
Mar 31, 2019 -1.70 Mn
Dec 31, 2018 1.30 Mn
Sep 30, 2018 -355,818.00
Jun 30, 2018 -310,156.00
Mar 31, 2018 1.37 Mn
Dec 31, 2017 -321,451.00